61
Participants
Start Date
January 31, 2013
Primary Completion Date
February 28, 2013
Study Completion Date
November 30, 2013
Synera (lidocaine 70mg/tetracaine 70mg)
All subjects will receive 2 patch applications during this study: one Synera, one placebo. The 2 patch applications must be done on separate days. Only 1 patch will be used per application. Arm 1 subjects will receive Synera patch for the 1st application, and placebo for the second. Arm 2 patients will receive placebo patch for the 1st application, and Synera patch for the second.
19 Locations Including, Dallas
Collaborators (1)
Nuvo Research Inc.
INDUSTRY
US Oncology Research
INDUSTRY